Related Experiment Video
Updated: Sep 3, 2025
Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Recent Insights into Pediatric Primary Sclerosing Cholangitis
James P Stevens1, Nitika A Gupta1
1Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 1760 Haygood Drive, Atlanta GA 30322, USA.
Insights
This review covers pediatric primary sclerosing cholangitis (PSC), exploring its causes, symptoms, and management. Understanding PSC in children remains challenging due to limited prospective data.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Autoimmune Diseases
Background:
- Pediatric primary sclerosing cholangitis (PSC) is a rare, chronic liver disease.
- Its pathogenesis, involving genetic and environmental factors, is not fully understood.
- PSC in children often presents with overlapping features of autoimmune hepatitis and inflammatory bowel disease.
Purpose of the Study:
- To review current literature on pediatric primary sclerosing cholangitis (PSC).
- To summarize knowledge regarding PSC pathogenesis, presentation, diagnosis, comorbidities, natural history, and management.
- To identify gaps in understanding and areas for future research.
Main Methods:
- Comprehensive literature review of recent studies on pediatric PSC.
- Synthesis of information on genetic and environmental factors.
- Analysis of clinical presentation, diagnostic criteria, and management strategies.
Main Results:
- Limited understanding of PSC pathogenesis despite identified genetic and environmental influences.
- Common phenotypes include association with inflammatory bowel disease and autoimmune hepatitis features.
- Lack of effective targeted therapies and limited prospective pediatric data are significant challenges.
Conclusions:
- Pediatric PSC is complex, with poorly understood etiology.
- Current management focuses on supportive care and complication management.
- Further prospective research is crucial to improve diagnosis and treatment for children with PSC.
Abstract:
This article reviews recent literature on the pathogenesis, presentation, diagnosis, comorbidities, natural history, and management of pediatric primary sclerosing cholangitis (PSC). The authors shed light on the role of genetic and environmental factors in PSC, although recognize the limitations in the understanding of PSC pathogenesis. They reflect on presenting disease phenotypes, including the association with inflammatory bowel disease and frequent histologic presence of autoimmune hepatitis features. The current lack of effective medications is discussed, and disease complications and prognosis are described. Finally, the authors highlight available evidence while acknowledging the paucity of prospective pediatric data.
More Related Videos
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...